72 related articles for article (PubMed ID: 27668860)
1. Mapping genetic factors in high-grade glioma patients.
Yuan Y; Yunhe M; Xiang W; Yanhui L; Ruofei L; Jiewen L; Qing M
Clin Neurol Neurosurg; 2016 Nov; 150():159-163. PubMed ID: 27668860
[TBL] [Abstract][Full Text] [Related]
2. Mapping seizure foci and tumor genetic factors in glioma associated seizure patients.
Yunhe M; Yuan Y; Xiang W; Yanhui L; Qing M
J Neurosurg Sci; 2020 Oct; 64(5):456-463. PubMed ID: 28497669
[TBL] [Abstract][Full Text] [Related]
3. Voxel-wise radiogenomic mapping of tumor location with key molecular alterations in patients with glioma.
Tejada Neyra MA; Neuberger U; Reinhardt A; Brugnara G; Bonekamp D; Sill M; Wick A; Jones DTW; Radbruch A; Unterberg A; Debus J; Heiland S; Schlemmer HP; Herold-Mende C; Pfister S; von Deimling A; Wick W; Capper D; Bendszus M; Kickingereder P
Neuro Oncol; 2018 Oct; 20(11):1517-1524. PubMed ID: 30107597
[TBL] [Abstract][Full Text] [Related]
4. PI3 kinase mutations and mutational load as poor prognostic markers in diffuse glioma patients.
Draaisma K; Wijnenga MM; Weenink B; Gao Y; Smid M; Robe P; van den Bent MJ; French PJ
Acta Neuropathol Commun; 2015 Dec; 3():88. PubMed ID: 26699864
[TBL] [Abstract][Full Text] [Related]
5. O6-methylguanine DNA methyltransferase gene promoter methylation status in gliomas and its correlation with other molecular alterations: first Indian report with review of challenges for use in customized treatment.
Jha P; Suri V; Jain A; Sharma MC; Pathak P; Jha P; Srivastava A; Suri A; Gupta D; Chosdol K; Chattopadhyay P; Sarkar C
Neurosurgery; 2010 Dec; 67(6):1681-91. PubMed ID: 21107199
[TBL] [Abstract][Full Text] [Related]
6. Association of tumor growth rates with molecular biomarker status: a longitudinal study of high-grade glioma.
Fan Z; Liu Y; Li S; Liu X; Jiang T; Wang Y; Wang L
Aging (Albany NY); 2020 May; 12(9):7908-7926. PubMed ID: 32388499
[TBL] [Abstract][Full Text] [Related]
7. TERT promoter mutations and long telomere length predict poor survival and radiotherapy resistance in gliomas.
Gao K; Li G; Qu Y; Wang M; Cui B; Ji M; Shi B; Hou P
Oncotarget; 2016 Feb; 7(8):8712-25. PubMed ID: 26556853
[TBL] [Abstract][Full Text] [Related]
8. Correlation of preoperative seizures with a wide range of tumor molecular markers in gliomas: An analysis of 442 glioma patients from China.
Shen S; Bai Y; Zhang B; Liu T; Yu X; Feng S
Epilepsy Res; 2020 Oct; 166():106430. PubMed ID: 32712511
[TBL] [Abstract][Full Text] [Related]
9. Probabilistic radiographic atlas of glioblastoma phenotypes.
Ellingson BM; Lai A; Harris RJ; Selfridge JM; Yong WH; Das K; Pope WB; Nghiemphu PL; Vinters HV; Liau LM; Mischel PS; Cloughesy TF
AJNR Am J Neuroradiol; 2013 Mar; 34(3):533-40. PubMed ID: 22997168
[TBL] [Abstract][Full Text] [Related]
10. Mapping p53 mutations in low-grade glioma: a voxel-based neuroimaging analysis.
Wang YY; Zhang T; Li SW; Qian TY; Fan X; Peng XX; Ma J; Wang L; Jiang T
AJNR Am J Neuroradiol; 2015 Jan; 36(1):70-6. PubMed ID: 25104286
[TBL] [Abstract][Full Text] [Related]
11. Input of molecular analysis in medical management of primary brain tumor patients.
Idbaih A; Duran-Peña A; Bonnet C; Ducray F
Rev Neurol (Paris); 2015; 171(6-7):457-65. PubMed ID: 26026669
[TBL] [Abstract][Full Text] [Related]
12. Combined IDH1 mutation and MGMT methylation status on long-term survival of patients with cerebral low-grade glioma.
Tanaka K; Sasayama T; Mizukawa K; Takata K; Sulaiman NS; Nishihara M; Kohta M; Sasaki R; Hirose T; Itoh T; Kohmura E
Clin Neurol Neurosurg; 2015 Nov; 138():37-44. PubMed ID: 26276726
[TBL] [Abstract][Full Text] [Related]
13. Genetic risk variants in the CDKN2A/B, RTEL1 and EGFR genes are associated with somatic biomarkers in glioma.
Ghasimi S; Wibom C; Dahlin AM; Brännström T; Golovleva I; Andersson U; Melin B
J Neurooncol; 2016 May; 127(3):483-92. PubMed ID: 26839018
[TBL] [Abstract][Full Text] [Related]
14. (11)C-methinine uptake correlates with MGMT promoter methylation in nonenhancing gliomas.
Okita Y; Nonaka M; Shofuda T; Kanematsu D; Yoshioka E; Kodama Y; Mano M; Nakajima S; Kanemura Y
Clin Neurol Neurosurg; 2014 Oct; 125():212-6. PubMed ID: 25178915
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of O6-methylguanine-DNA methyltransferase determined by promoter hypermethylation and immunohistochemical expression in anaplastic gliomas.
Brell M; Tortosa A; Verger E; Gil JM; Viñolas N; Villá S; Acebes JJ; Caral L; Pujol T; Ferrer I; Ribalta T; Graus F
Clin Cancer Res; 2005 Jul; 11(14):5167-74. PubMed ID: 16033832
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical profiles of IDH1, MGMT and P53: practical significance for prognostication of patients with diffuse gliomas.
Ogura R; Tsukamoto Y; Natsumeda M; Isogawa M; Aoki H; Kobayashi T; Yoshida S; Okamoto K; Takahashi H; Fujii Y; Kakita A
Neuropathology; 2015 Aug; 35(4):324-35. PubMed ID: 25950388
[TBL] [Abstract][Full Text] [Related]
17. IDH mutation, 1p19q codeletion and ATRX loss in WHO grade II gliomas.
Leeper HE; Caron AA; Decker PA; Jenkins RB; Lachance DH; Giannini C
Oncotarget; 2015 Oct; 6(30):30295-305. PubMed ID: 26210286
[TBL] [Abstract][Full Text] [Related]
18. The tumoral A genotype of the MGMT rs34180180 single-nucleotide polymorphism in aggressive gliomas is associated with shorter patients' survival.
Fogli A; Chautard E; Vaurs-Barrière C; Pereira B; Müller-Barthélémy M; Court F; Biau J; Pinto AA; Kémény JL; Khalil T; Karayan-Tapon L; Verrelle P; Costa BM; Arnaud P
Carcinogenesis; 2016 Feb; 37(2):169-176. PubMed ID: 26717998
[TBL] [Abstract][Full Text] [Related]
19. Molecular classification of anaplastic oligodendroglioma using next-generation sequencing: a report of the prospective randomized EORTC Brain Tumor Group 26951 phase III trial.
Dubbink HJ; Atmodimedjo PN; Kros JM; French PJ; Sanson M; Idbaih A; Wesseling P; Enting R; Spliet W; Tijssen C; Dinjens WN; Gorlia T; van den Bent MJ
Neuro Oncol; 2016 Mar; 18(3):388-400. PubMed ID: 26354927
[TBL] [Abstract][Full Text] [Related]
20. Quantitative magnetic resonance imaging and radiogenomic biomarkers for glioma characterisation: a systematic review.
Seow P; Wong JHD; Ahmad-Annuar A; Mahajan A; Abdullah NA; Ramli N
Br J Radiol; 2018 Dec; 91(1092):20170930. PubMed ID: 29902076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
